Prime Medicine Inc PRME:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
7.19quote price arrow up+0.11 (+1.55%)
Volume
9,102
Close
7.08quote price arrow up+0.04 (+0.57%)
Volume
596,229
52 week range
4.11 - 17.20
Loading...
  • Open7.05
  • Day High7.18
  • Day Low6.87
  • Prev Close7.04
  • 52 Week High17.20
  • 52 Week High Date06/07/23
  • 52 Week Low4.11
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap849.804M
  • Shares Out120.03M
  • 10 Day Average Volume0.83M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-20.09

KEY STATS

  • Open7.05
  • Day High7.18
  • Day Low6.87
  • Prev Close7.04
  • 52 Week High17.20
  • 52 Week High Date06/07/23
  • 52 Week Low4.11
  • 52 Week Low Date04/25/24
  • Market Cap849.804M
  • Shares Out120.03M
  • 10 Day Average Volume0.83M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-20.09

RATIOS/PROFITABILITY

  • EPS (TTM)-2.17
  • P/E (TTM)-3.26
  • Fwd P/E (NTM)-4.11
  • EBITDA (TTM)-208.184M
  • ROE (TTM)-78.27%
  • Revenue (TTM)591,000.021
  • Gross Margin (TTM)-
  • Net Margin (TTM)-34,601.86%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Prime Medicine, Inc. is a biotechnology company engaged in creating and delivering the gene editing therapies to patients. It deploys its Prime Editing platform, a gene editing technology, to develop a new class of differentiated, one-time genetic therapies. It is engaged in developing Prime Editors as a new class of therapeutics with transformative potential to expand the application of curative precision genetic medicines. It has built a diversified portfolio of...
Keith Gottesdiener M.D.
President, Chief Executive Officer, Director
Allan Reine M.D.
Chief Financial Officer
Ann Lee Ph.D.
Chief Technical Officer
Address
21 Erie Street
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
MLYS
Mineralys Therapeutics Inc
13.00-0.15-1.14%
GHRS
GH Research PLC
12.60-0.13-1.02%
HLVX
Hillevax Inc
15.84+0.27+1.73%
SVRA
Savara Inc
4.48-0.24-5.08%
LXRX
Lexicon Pharmaceuticals Inc
1.77-0.07-3.80%